Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease ; volume:7 ; number:1 ; day:18 ; month:12 ; year:2015 ; pages:1-11 ; date:12.2015
Alzheimer's research & therapy ; 7, Heft 1 (18.12.2015), 1-11, 12.2015

Urheber
Adamczuk, Katarzyna
Beteiligte Personen und Organisationen
Schaeverbeke, Jolien
Vanderstichele, Hugo M. J.
Lilja, Johan
Nelissen, Natalie
Van Laere, Koen
Dupont, Patrick
Hilven, Kelly
Poesen, Koen
Vandenberghe, Rik
SpringerLink (Online service)

DOI
10.1186/s13195-015-0159-5
URN
urn:nbn:de:1111-2016042126907
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:58 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Adamczuk, Katarzyna
  • Schaeverbeke, Jolien
  • Vanderstichele, Hugo M. J.
  • Lilja, Johan
  • Nelissen, Natalie
  • Van Laere, Koen
  • Dupont, Patrick
  • Hilven, Kelly
  • Poesen, Koen
  • Vandenberghe, Rik
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimer disease pathology and the cerebrospinal fluid proteome

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

Verbundene Objekte